{"title":"空气污染物暴露与乳腺癌风险:E3N-Generations 队列中一项巢式病例对照研究中代谢健康生物标志物的中介效应。","authors":"Benoît Mercoeur, Béatrice Fervers, Thomas Coudon, Hwayoung Noh, Camille Giampiccolo, Lény Grassot, Elodie Faure, Florian Couvidat, Gianluca Severi, Francesca Romana Mancini, Pascal Roy, Delphine Praud, Amina Amadou","doi":"10.1186/s13058-024-01913-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Growing epidemiological evidence suggests an association between exposure to air pollutants and breast cancer. Yet, the underlying mechanisms remain poorly understood. This study explored the mediating role of thirteen metabolic health biomarkers in the relationship between exposure to three air pollutants, i.e. nitrogen dioxide (NO<sub>2</sub>), polychlorinated biphenyls 153 (PCB153), and benzo[a]pyrene (BaP), and breast cancer risk.</p><p><strong>Methods: </strong>We used data from a nested case-control study within the French national prospective E3N-Generations cohort, involving 523 breast cancer cases and 523 matched controls. The four-way decomposition mediation of total effects for thirteen biomarkers was applied to estimate interaction and mediation effects (controlled direct, reference interaction, mediated interaction, and pure indirect effects).</p><p><strong>Results: </strong>The analyses indicated a significant increase in breast cancer risk associated with BaP exposure (odds ratio (OR)<sub>Q4 vs Q1</sub> = 2.32, 95% confidence intervals (CI): 1.00-5.37). PCB153 exposure showed a positive association only in the third quartile (OR<sub>Q3 vs Q1</sub> = 2.25, CI 1.13-4.57), but it appeared to be non-significant in the highest quartile (OR<sub>Q4 vs Q1</sub> = 2.07, CI 0.93-4.61). No association was observed between NO<sub>2</sub> exposure and breast cancer risk. Estradiol was associated with an increased risk of breast cancer (OR per one standard deviation (SD) increment = 1.22, CI 1.05-1.42), while thyroid-stimulating hormone was inversely related to breast cancer risk (OR per 1SD increase = 0.87, CI 0.75-1.00). We observed a suggestive mediated effect of the association between the three pollutants and breast cancer risk, through albumin, high-density lipoproteins cholesterol, low-density lipoprotein cholesterol, parathormone, and estradiol.</p><p><strong>Conclusion: </strong>Although limited by a lack of statistical power, this study provides relevant insights into the potential mediating role of certain biomarkers in the association between air pollutant exposure and breast cancer risk, highlighting the need for further in-depth studies in large populations.</p>","PeriodicalId":49227,"journal":{"name":"Breast Cancer Research","volume":"26 1","pages":"159"},"PeriodicalIF":7.4000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568591/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exposure to air pollutants and breast cancer risk: mediating effects of metabolic health biomarkers in a nested case-control study within the E3N-Generations cohort.\",\"authors\":\"Benoît Mercoeur, Béatrice Fervers, Thomas Coudon, Hwayoung Noh, Camille Giampiccolo, Lény Grassot, Elodie Faure, Florian Couvidat, Gianluca Severi, Francesca Romana Mancini, Pascal Roy, Delphine Praud, Amina Amadou\",\"doi\":\"10.1186/s13058-024-01913-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Growing epidemiological evidence suggests an association between exposure to air pollutants and breast cancer. Yet, the underlying mechanisms remain poorly understood. This study explored the mediating role of thirteen metabolic health biomarkers in the relationship between exposure to three air pollutants, i.e. nitrogen dioxide (NO<sub>2</sub>), polychlorinated biphenyls 153 (PCB153), and benzo[a]pyrene (BaP), and breast cancer risk.</p><p><strong>Methods: </strong>We used data from a nested case-control study within the French national prospective E3N-Generations cohort, involving 523 breast cancer cases and 523 matched controls. The four-way decomposition mediation of total effects for thirteen biomarkers was applied to estimate interaction and mediation effects (controlled direct, reference interaction, mediated interaction, and pure indirect effects).</p><p><strong>Results: </strong>The analyses indicated a significant increase in breast cancer risk associated with BaP exposure (odds ratio (OR)<sub>Q4 vs Q1</sub> = 2.32, 95% confidence intervals (CI): 1.00-5.37). PCB153 exposure showed a positive association only in the third quartile (OR<sub>Q3 vs Q1</sub> = 2.25, CI 1.13-4.57), but it appeared to be non-significant in the highest quartile (OR<sub>Q4 vs Q1</sub> = 2.07, CI 0.93-4.61). No association was observed between NO<sub>2</sub> exposure and breast cancer risk. Estradiol was associated with an increased risk of breast cancer (OR per one standard deviation (SD) increment = 1.22, CI 1.05-1.42), while thyroid-stimulating hormone was inversely related to breast cancer risk (OR per 1SD increase = 0.87, CI 0.75-1.00). We observed a suggestive mediated effect of the association between the three pollutants and breast cancer risk, through albumin, high-density lipoproteins cholesterol, low-density lipoprotein cholesterol, parathormone, and estradiol.</p><p><strong>Conclusion: </strong>Although limited by a lack of statistical power, this study provides relevant insights into the potential mediating role of certain biomarkers in the association between air pollutant exposure and breast cancer risk, highlighting the need for further in-depth studies in large populations.</p>\",\"PeriodicalId\":49227,\"journal\":{\"name\":\"Breast Cancer Research\",\"volume\":\"26 1\",\"pages\":\"159\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568591/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13058-024-01913-7\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13058-024-01913-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:越来越多的流行病学证据表明,暴露于空气污染物与乳腺癌之间存在关联。然而,人们对其潜在机制仍然知之甚少。本研究探讨了 13 种代谢健康生物标志物在暴露于三种空气污染物(即二氧化氮(NO2)、多氯联苯 153(PCB153)和苯并[a]芘(BaP))与乳腺癌风险之间关系中的中介作用:我们使用了法国国家前瞻性 E3N-Generations 队列中一项嵌套病例对照研究的数据,其中包括 523 例乳腺癌病例和 523 例匹配对照。我们对 13 种生物标志物的总效应进行了四向分解中介,以估计交互作用和中介效应(受控直接效应、参考交互作用、中介交互作用和纯间接效应):分析表明,暴露于 BaP 会显著增加乳腺癌风险(几率比 (OR)Q4 vs Q1 = 2.32,95% 置信区间 (CI):1.00-5.37)。PCB153 暴露仅在第三四分位数(ORQ3 vs Q1 = 2.25,CI 1.13-4.57)中显示出正相关,但在最高四分位数(ORQ4 vs Q1 = 2.07,CI 0.93-4.61)中似乎并不显著。未观察到二氧化氮暴露与乳腺癌风险之间存在关联。雌二醇与乳腺癌风险增加有关(每增加一个标准差的 OR = 1.22,CI 1.05-1.42),而促甲状腺激素与乳腺癌风险成反比(每增加一个标准差的 OR = 0.87,CI 0.75-1.00)。我们观察到,通过白蛋白、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、促甲状腺激素和雌二醇,这三种污染物与乳腺癌风险之间的关系具有暗示性的中介效应:本研究虽然受限于统计能力的不足,但对某些生物标志物在空气污染物暴露与乳腺癌风险之间的潜在中介作用提供了相关见解,强调了在大量人群中开展进一步深入研究的必要性。
Exposure to air pollutants and breast cancer risk: mediating effects of metabolic health biomarkers in a nested case-control study within the E3N-Generations cohort.
Background: Growing epidemiological evidence suggests an association between exposure to air pollutants and breast cancer. Yet, the underlying mechanisms remain poorly understood. This study explored the mediating role of thirteen metabolic health biomarkers in the relationship between exposure to three air pollutants, i.e. nitrogen dioxide (NO2), polychlorinated biphenyls 153 (PCB153), and benzo[a]pyrene (BaP), and breast cancer risk.
Methods: We used data from a nested case-control study within the French national prospective E3N-Generations cohort, involving 523 breast cancer cases and 523 matched controls. The four-way decomposition mediation of total effects for thirteen biomarkers was applied to estimate interaction and mediation effects (controlled direct, reference interaction, mediated interaction, and pure indirect effects).
Results: The analyses indicated a significant increase in breast cancer risk associated with BaP exposure (odds ratio (OR)Q4 vs Q1 = 2.32, 95% confidence intervals (CI): 1.00-5.37). PCB153 exposure showed a positive association only in the third quartile (ORQ3 vs Q1 = 2.25, CI 1.13-4.57), but it appeared to be non-significant in the highest quartile (ORQ4 vs Q1 = 2.07, CI 0.93-4.61). No association was observed between NO2 exposure and breast cancer risk. Estradiol was associated with an increased risk of breast cancer (OR per one standard deviation (SD) increment = 1.22, CI 1.05-1.42), while thyroid-stimulating hormone was inversely related to breast cancer risk (OR per 1SD increase = 0.87, CI 0.75-1.00). We observed a suggestive mediated effect of the association between the three pollutants and breast cancer risk, through albumin, high-density lipoproteins cholesterol, low-density lipoprotein cholesterol, parathormone, and estradiol.
Conclusion: Although limited by a lack of statistical power, this study provides relevant insights into the potential mediating role of certain biomarkers in the association between air pollutant exposure and breast cancer risk, highlighting the need for further in-depth studies in large populations.
期刊介绍:
Breast Cancer Research, an international, peer-reviewed online journal, publishes original research, reviews, editorials, and reports. It features open-access research articles of exceptional interest across all areas of biology and medicine relevant to breast cancer. This includes normal mammary gland biology, with a special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal covers preclinical, translational, and clinical studies with a biological basis, including Phase I and Phase II trials.